These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5015339)

  • 21. Drugs for leprosy.
    Rees RJ
    Trop Doct; 1973 Apr; 3(2):92-5. PubMed ID: 4691437
    [No Abstract]   [Full Text] [Related]  

  • 22. B.663 and erythema nodosum leprosum.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
    [No Abstract]   [Full Text] [Related]  

  • 23. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
    Schulz EJ
    Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
    [No Abstract]   [Full Text] [Related]  

  • 24. Erythema nodosum leprosum.
    Fowler PD
    Int J Lepr Other Mycobact Dis; 1967; 35(3):397-8. PubMed ID: 4318423
    [No Abstract]   [Full Text] [Related]  

  • 25. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of skin pigmentation by clofazimine.
    Levy L; Randall HP
    Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
    [No Abstract]   [Full Text] [Related]  

  • 27. A study of clofazimine in the rat.
    Currey HL; Fowler PD
    Br J Pharmacol; 1972 Aug; 45(4):676-81. PubMed ID: 5085241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of leprosy with Lampren (B.663 Geigy).
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
    [No Abstract]   [Full Text] [Related]  

  • 30. Story behind the clinical trial of B.663 in leprosy.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lampren in the treatment of leprosy].
    Ahrens T
    Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
    [No Abstract]   [Full Text] [Related]  

  • 32. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 33. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 35. Clofazimine: current status and future prospects.
    Cholo MC; Steel HC; Fourie PB; Germishuizen WA; Anderson R
    J Antimicrob Chemother; 2012 Feb; 67(2):290-8. PubMed ID: 22020137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 38. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
    Pene P; Carrie J; Bourgeade A; Bolliot Y
    Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of B.663 in human leprosy.
    Atkinson AJ; Sheagren JN; Rubio JB; Knight V
    Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
    [No Abstract]   [Full Text] [Related]  

  • 40. Phagocytosis-promoting effect of clofazimine (B 663) in patients with subnormal granulocyte function.
    Brandt L
    Scand J Haematol; 1971; 8(5):400-4. PubMed ID: 5289696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.